NY Times: For Science Gatekeepers, a Credibility Gap???

<<< Back to Pharmacartel Articles

<<< Back to Drug Companies

Hello friends, family, (romans), countrymen,

Blogaroo

The NY Times science writer Lawrence Altman reports that studies in our medical journals (and drugs they recommend, and the belief systems they support or impart) are not necessarily sound - and that peer review often fails to ensure ethics and accuracy.

From the piece:

"Recent disclosures of fraudulent or flawed studies in medical and scientific journals have called into question as never before the merits of their peer-review system....Many factors can allow error, even fraud, to slip through."

"By promoting the sanctity of peer review and using it to justify a number of their actions in recent years, journals have added to their enormous power....Except when gaffes are publicized, there is little scrutiny of the quality of what journals publish."

"The journals rely on revenues from industry advertisements. But because journals also profit handsomely by selling drug companies reprints of articles reporting findings from large clinical trials involving their products, editors may "face a frighteningly stark conflict of interest" in deciding whether to publish such a study."

------

Well, yeah. I've been pointing that out for awhile, even to some of the regulars at this site, who like to drop academic abstracts like Poseidon's tridents, and blow their trumpets hard.

What the Times says, goes, in the sciences; so I'm pleased to let you know that you are now allowed to consider that what scientists say, even in their big, fat peer-reviewed journals, ain't necessarily so.

Continues here: with Times article linked (worth reading, and that's no lie!): www.gnn.tv/A02262

Back to top of Document